7.8
HIGH
CVE-2018-14787
Philips IntelliSpace Cardiovascular Local Privilege Escalation
Description

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

INFO

Published Date :

Aug. 22, 2018, 6:29 p.m.

Last Modified :

Nov. 21, 2024, 3:49 a.m.

Remotely Exploitable :

No

Impact Score :

5.9

Exploitability Score :

1.8
Affected Products

The following products are affected by CVE-2018-14787 vulnerability. Even if cvefeed.io is aware of the exact versions of the products that are affected, the information is not represented in the table below.

ID Vendor Product Action
1 Philips intellispace_cardiovascular
2 Philips xcelera
References to Advisories, Solutions, and Tools

Here, you will find a curated list of external links that provide in-depth information, practical solutions, and valuable tools related to CVE-2018-14787.

URL Resource
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 Third Party Advisory US Government Resource
https://www.usa.philips.com/healthcare/about/customer-support/product-security Vendor Advisory
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 Third Party Advisory US Government Resource
https://www.usa.philips.com/healthcare/about/customer-support/product-security Vendor Advisory

We scan GitHub repositories to detect new proof-of-concept exploits. Following list is a collection of public exploits and proof-of-concepts, which have been published on GitHub (sorted by the most recently updated).

Results are limited to the first 15 repositories due to potential performance issues.

The following list is the news that have been mention CVE-2018-14787 vulnerability anywhere in the article.

The following table lists the changes that have been made to the CVE-2018-14787 vulnerability over time.

Vulnerability history details can be useful for understanding the evolution of a vulnerability, and for identifying the most recent changes that may impact the vulnerability's severity, exploitability, or other characteristics.

  • CVE Modified by af854a3a-2127-422b-91ae-364da2661108

    Nov. 21, 2024

    Action Type Old Value New Value
    Added Reference https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
    Added Reference https://www.usa.philips.com/healthcare/about/customer-support/product-security
  • CVE Modified by [email protected]

    May. 14, 2024

    Action Type Old Value New Value
  • Modified Analysis by [email protected]

    Apr. 22, 2022

    Action Type Old Value New Value
    Removed CVSS V3 NIST AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
    Added CVSS V3.1 NIST AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
  • CPE Deprecation Remap by [email protected]

    Feb. 09, 2022

    Action Type Old Value New Value
    Changed CPE Configuration OR *cpe:2.3:a:phillips:intellispace_cardiovascular:*:*:*:*:*:*:*:* versions from (including) 3.1 OR *cpe:2.3:a:philips:intellispace_cardiovascular:*:*:*:*:*:*:*:* versions from (including) 3.1
  • CPE Deprecation Remap by [email protected]

    Feb. 09, 2022

    Action Type Old Value New Value
    Changed CPE Configuration OR *cpe:2.3:a:phillips:xcelera:*:*:*:*:*:*:*:* versions from (including) 4.1 OR *cpe:2.3:a:philips:xcelera:*:*:*:*:*:*:*:* versions from (including) 4.1
  • CVE Modified by [email protected]

    Oct. 09, 2019

    Action Type Old Value New Value
    Added CWE ICS-CERT CWE-269
  • CWE Remap by [email protected]

    Oct. 03, 2019

    Action Type Old Value New Value
    Changed CWE CWE-264 CWE-264 CWE-269
  • Initial Analysis by [email protected]

    Nov. 05, 2018

    Action Type Old Value New Value
    Added CVSS V2 (AV:L/AC:L/Au:N/C:P/I:P/A:P)
    Added CVSS V3 AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
    Changed Reference Type https://www.usa.philips.com/healthcare/about/customer-support/product-security No Types Assigned https://www.usa.philips.com/healthcare/about/customer-support/product-security Vendor Advisory
    Changed Reference Type https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 No Types Assigned https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 Third Party Advisory, US Government Resource
    Added CWE CWE-264
    Added CPE Configuration OR *cpe:2.3:a:phillips:intellispace_cardiovascular:*:*:*:*:*:*:*:* versions up to (including) 3.1 *cpe:2.3:a:phillips:xcelera:*:*:*:*:*:*:*:* versions up to (including) 4.1
EPSS is a daily estimate of the probability of exploitation activity being observed over the next 30 days. Following chart shows the EPSS score history of the vulnerability.
CWE - Common Weakness Enumeration

While CVE identifies specific instances of vulnerabilities, CWE categorizes the common flaws or weaknesses that can lead to vulnerabilities. CVE-2018-14787 is associated with the following CWEs:

Common Attack Pattern Enumeration and Classification (CAPEC)

Common Attack Pattern Enumeration and Classification (CAPEC) stores attack patterns, which are descriptions of the common attributes and approaches employed by adversaries to exploit the CVE-2018-14787 weaknesses.

Exploit Prediction

EPSS is a daily estimate of the probability of exploitation activity being observed over the next 30 days.

0.13 }} 0.08%

score

0.47765

percentile

CVSS31 - Vulnerability Scoring System
Attack Vector
Attack Complexity
Privileges Required
User Interaction
Scope
Confidentiality
Integrity
Availability